PRKN and type 2 diabetes mellitus: MitoQ, a mitochondria‐targeted antioxidant, can exert a protective effect on cardiomyocytes after MIR in T2DM by increasing its expression level through PINK1/Parkin pathway‐mediated mitophagy.47